Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia / Joanna Caroline Neill en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.5 (Mayo)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.5 (Mayo) . - pp. 822-835 Título : Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia : A translational link to humans Tipo de documento: texto impreso Autores: Joanna Caroline Neill, Autor ; Michael K. Harte, Autor ; Peter Haddad, Autor Fecha de publicación: 2021 Artículo en la página: pp. 822-835 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antagonistas del receptor NMDA, Síntomas negativos, Anhedonia, Retiro social, Modelos animales, Esquizofrenia, Motivación Resumen: Negative symptoms of schizophrenia remain an unmet clinical need as they are common, persistent, respond poorly to existing treatments and lead to disability. Blunted affect, alogia, asociality, anhedonia and avolition are regarded as key negative symptoms despite DSM-IV-TR specifying a more limited range. Link: ./index.php?lvl=notice_display&id=26995 [artículo] Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia : A translational link to humans [texto impreso] / Joanna Caroline Neill, Autor ; Michael K. Harte, Autor ; Peter Haddad, Autor . - 2021 . - pp. 822-835. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.5 (Mayo) . - pp. 822-835 Palabras clave: Antagonistas del receptor NMDA, Síntomas negativos, Anhedonia, Retiro social, Modelos animales, Esquizofrenia, Motivación Resumen: Negative symptoms of schizophrenia remain an unmet clinical need as they are common, persistent, respond poorly to existing treatments and lead to disability. Blunted affect, alogia, asociality, anhedonia and avolition are regarded as key negative symptoms despite DSM-IV-TR specifying a more limited range. Link: ./index.php?lvl=notice_display&id=26995

Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology / Joanna Caroline Neill en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No.1 (Enero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No.1 (Enero) . - pp. 3-14 Título : Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology Tipo de documento: texto impreso Autores: Joanna Caroline Neill, Autor ; Ben Grayson, Autor ; Béla Kiss, Autor Fecha de publicación: 2021 Artículo en la página: pp. 3-14 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cariprazina,Receptor de dopamina D3, Esquizofrenia, Fenciclidina (PCP), Cognición, Síntomas negativos Resumen: Negative symptoms and cognitive impairment associated with schizophrenia are strongly associated with poor functional outcome and reduced quality of life and remain an unmet clinical need. Link: ./index.php?lvl=notice_display&id=26622 [artículo] Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology [texto impreso] / Joanna Caroline Neill, Autor ; Ben Grayson, Autor ; Béla Kiss, Autor . - 2021 . - pp. 3-14. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No.1 (Enero) . - pp. 3-14 Palabras clave: Cariprazina,Receptor de dopamina D3, Esquizofrenia, Fenciclidina (PCP), Cognición, Síntomas negativos Resumen: Negative symptoms and cognitive impairment associated with schizophrenia are strongly associated with poor functional outcome and reduced quality of life and remain an unmet clinical need. Link: ./index.php?lvl=notice_display&id=26622

---

1 (1 - 2 / 2)